NeoGen Labs

Bengaluru, India Founded: 2006 • Age: 20 yrs
Neonatal diagnostic solutions for the detection of inborn errors of metabolism
Annual revenue $913,698 Latest available
Total funding $453,144 4 rounds
Employees 25 Tracked headcount
Investors 18 Known backers
Products 1 Services tracked
Competitors 11 Brand Intelligence

About NeoGen Labs

NeoGen Labs is a company based in Bengaluru (India) founded in 2006 by Thomas Mookken. NeoGen Labs has raised $453.14 thousand across 4 funding rounds from investors including Bhagwati Spherocast, Nihal George and Aanal Bhagwati. The company has 25 employees as of April 03, 2024. NeoGen Labs has completed 1 acquisition, including Lab M. NeoGen Labs offers products and services including First Step Newborn Screening. NeoGen Labs operates in a competitive market with competitors including Natera, Metabolon, Progenity, SYNLAB and Blueprint Genetics, among others.

  • Headquarter Bengaluru, India
  • Employees 25 as on 03 Apr, 2024
  • Founders Thomas Mookken
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Neogen Labs Private Limited
  • Date of Incorporation 29 Jun, 2006
  • Jurisdiction Ahmedabad, Gujarat, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $913.7 K (USD)
    -15.34
    as on Mar 31, 2022
  • Net Profit
    $29.07 K (USD)
    -87.85
    as on Mar 31, 2022
  • EBITDA
    $126.42 K (USD)
    -69.78
    as on Mar 31, 2022
  • Total Equity Funding
    $453.14 K (USD)

    in 4 rounds

  • Latest Funding Round
    $55.63 K (USD), Angel Round

    Mar 15, 2011

  • Investors
  • Employee Count
    25

    as on Apr 03, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of NeoGen Labs

NeoGen Labs offers a comprehensive portfolio of products and services, including First Step Newborn Screening.

Product name locked
Category locked
Primary

Test to detect metabolic disorders in newborns

Funding Insights of NeoGen Labs

NeoGen Labs has successfully raised a total of $453.14K across 4 strategic funding rounds. The most recent funding activity was a Angel Round of $55.63 thousand completed in March 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in NeoGen Labs

NeoGen Labs has secured backing from 18 investors, including angel and institutional investors. Prominent investors backing the company include Bhagwati Spherocast, Nihal George and Aanal Bhagwati.

All
Institutional
Angel
Investor Description Founded Year Domain Location
Control system components manufactured for tier 1 suppliers and OEMs.
Locked Locked Locked

Nihal George

-
Locked Locked Locked

Aanal Bhagwati

-
Locked Locked Locked
Premium access

Investor details for NeoGen Labs

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by NeoGen Labs

NeoGen Labs has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lab M.

Investments
Premium access

Investment portfolio details for NeoGen Labs

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Manufactures microbiology products
Locked Locked 1971 Locked
Premium access

Complete acquisition details for NeoGen Labs

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - NeoGen Labs

Premium access

Detailed financials for NeoGen Labs

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Neogen Labs Comparisons

NeoGen Labs Primary company
Description
Neonatal diagnostic solutions for the detection of inborn er...
Location
Bengaluru, India
Founded Year
2006
Annual Revenue
$913.7 K (USD)
Net Profit
$29.07 K (USD)
EBITDA
$126.42 K (USD)
Employees
25
As of 2024
Premium access

Peer comparison for NeoGen Labs

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of NeoGen Labs

NeoGen Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, Metabolon, Progenity, SYNLAB and Blueprint Genetics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of cell-free DNA testing for oncology, women’s health, and organ health
Locked Locked Locked
Solutions for biomarker discovery and diagnostic testing are provided.
Locked Locked Locked
Non-invasive prenatal genomic testing is provided for genetic disorders.
Locked Locked Locked
Provider of medical diagnosis and clinical laboratory analysis services
Locked Locked Locked
Genetic diagnostics and clinical interpretation for hereditary diseases are provided.
Locked Locked Locked
NGS-based diagnostic solutions for neonatal screening are developed.
Premium access

Detailed competitors of NeoGen Labs

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Neogen Labs

Premium access

Complete news archive for NeoGen Labs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NeoGen Labs

NeoGen Labs was founded in 2006 and raised its 1st funding round 1 year after it was founded.

NeoGen Labs is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Thomas Mookken is the current CEO of NeoGen Labs. They have also founded this company.

NeoGen Labs is a funded company, having raised a total of $453.14K across 4 funding rounds to date.

As of Apr 03, 2024, the latest employee count at NeoGen Labs is 25.

Annual revenue of NeoGen Labs is $913.7K as on Mar 31, 2022.

NeoGen Labs develops neonatal diagnostic solutions for the detection of inborn errors of metabolism (IEM). Its flagship product First Step Newborn Screening program is a metabolomics assay that tests for 47 IEM disorders using tandem mass spectrometry (MSMS). The assay is based on the American College of Medical Genetics (ACMG) Core and Secondary panels. The technology has been licensed from PerkinElmer Genetics.

NeoGen Labs's top competitors include Natera, Metabolon and SYNLAB.

NeoGen Labs offers First Step Newborn Screening.

NeoGen Labs has made 1 acquisition, including Lab M.

NeoGen Labs has 18 investors. Key investors include Bhagwati Spherocast, Nihal George, Aanal Bhagwati, Mandakini Bhagwati, and Arti Chaterjee.

The valuation of NeoGen Labs is $977.49K as of Mar 2011.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available